Diagnostics and Therapeutic Potential of miR-205 and miR-34a in Ovarian Cancer Management: A miRNA-Target-Based Analysis.


Journal

DNA and cell biology
ISSN: 1557-7430
Titre abrégé: DNA Cell Biol
Pays: United States
ID NLM: 9004522

Informations de publication

Date de publication:
Mar 2023
Historique:
pubmed: 14 2 2023
medline: 17 3 2023
entrez: 13 2 2023
Statut: ppublish

Résumé

Epithelial ovarian cancer (EOC) treatment strategies mainly focused on surgery combined with chemotherapy. Recent targeted therapy techniques emerge as milestone and could be used for management of ovarian cancer (OC) progression with more efficacy. The aim is to evaluate the therapeutic and diagnostic potential of microRNA (miRNA) in management of EOC using

Identifiants

pubmed: 36779980
doi: 10.1089/dna.2022.0487
doi:

Substances chimiques

MIRN205 microRNA, human 0
MIRN34 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-162

Auteurs

Vivek Kumar (V)

Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, Prayagraj, India.

Archana Pandey (A)

Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, Prayagraj, India.

Arisha Arora (A)

Department of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati, Assam, India.

Priyanka Gautam (P)

Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, Prayagraj, India.

Deepa Bisht (D)

Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, Prayagraj, India.

Sameer Gupta (S)

Department of Surgical Oncology, King George Medical University, Lucknow, India.

Amrita Chaurasia (A)

Department of Gynaecology and Obstetrics, Motilal Nehru Medical College Allahabad, Allahabad, Prayagraj, India.

Manisha Sachan (M)

Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, Prayagraj, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH